ngland District Office, where he provided executive direction to consumer protection and enforcement programs throughout the New England States and earned the FDA Award of merit for precedent enforcement actions. During his ten years as Director, Division of Compliance Programs at the FDA's, Center for Devices and Radiological Health, he was responsible for the development and application of Good Manufacturing Regulations (GMPs) for the manufacture of medical devices and for the implementation of new medical device legislation. . McDonnell started his FDA career as a Food and Drug Inspector in the Boston District Office specializing in the inspection of drug and device manufacturers. At the conclusion of his FDA career he was awarded the FDA Distinguished Career Service Award
Mr. McDonnell earned a M.P.H., in Health Business Administration from the University of Michigan, School of Public Health, Ann Arbor, MI and a B.A., in Biology from Boston University, College of Liberal Arts, Boston, MA. Mr. McDonnell resides in both Ormond Beach, FL. and Lowell, MA.
About Rock Creek Pharmaceuticals, Inc.:
Rock Creek Pharmaceuticals, Inc. is an emerging drug development company focused on the discovery, development and commercialization of new drugs, formulations and compounds that provide therapies for inflammatory conditions and behavioral health. Additionally, through its subsidiary RCP Development, the Company is engaged in the manufacturing and sale of nutraceutical dietary supplements designed to promote maintenance of a healthy metabolism and lifestyle.
For more information, visit: http://www.rockcreekpharma.com
Vice President, Corporate Strategy, Development, Investor Relations
Rock Creek Pharmaceuticals
Page: 1 2 3 4 Related medicine technology :1
|SOURCE Rock Creek Pharmaceuticals, Inc.|
Copyright©2014 PR Newswire.
All rights reserved
. Rock Creek Pharmaceuticals to Present at the Annual BioPharm America International Partnering Conference2
. Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs3
. Creekridge Capital Signs Several New Vendor Partners4
. Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application5
. Creekridge Breaks Monthly and Quarterly Volume Records6
. Creekridge Capital Grows Healthcare Sales Team7
. Creekridge Capital Launches Vendor Sales Training Program8
. Creekridge Capital Expands Healthcare Sales Team9
. Creekridge Capital Adds Revolving Credit Specialist10
. Creekridge Capital Announces Record Volume11
. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis